NASDAQ$ASRT

Assertio Holdings Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Assertio's Q4 2023 results reflected positive indicators, including solid net product sales and positive cash flows, despite declines in Indocin and Cambia sales.

Assertio Holdings, Inc. reported Q4 net product sales of $32.5 million and cash flow from operations of $5.7 million. The company is providing guidance for 2024, targeting net product sales of $110 million to $125 million and adjusted EBITDA of $20 million to $30 million.

  • Net product sales were $32.5 million, a decrease from $49.9 million in the prior year fourth quarter.
  • Rolvedon net product sales were $11.0 million in the fourth quarter, the first full quarter following the acquisition of Spectrum.
  • Indocin net product sales in the fourth quarter were $10.8 million, a decrease from the prior year quarter due to declining price and volumes.
  • Adjusted EBITDA was $4.5 million, decreased from $33.4 million in the prior year fourth quarter, primarily due to Indocin generic competition and higher operating expenses from the acquisition of Spectrum.

Headline financials

Total Revenue

$33M

Previous: $50.4M-34.5%
EPS (adj)

$0.11

Previous: $0.32-65.6%
SG&A Expenses

$24M

No prior period
Capital Expenditures

-$100K

Previous: $274K-136.5%
Net Income

-$57.4M

Previous: $88.6M-164.8%
Operating Income

-$32.3M

Previous: $10.6M-404.4%
Gross Profit

$22.7M

Previous: $44.3M-48.7%
R&D Expense

$1.02M

No prior period
Stock-Based Comp

$2.64M

Previous: $2.39M+10.6%

Revenue & EPS history

Assertio · Revenue · Quarterly

$33M

Q4 2023-34.5%vs Q4 2022
Beat estimate in 11 of 14 quarters(79%)
ActualEstimate

Revenue by segment

Assertio · $40.1M total across 1 segment · Q2 2023

  • Net Product Sales
    $40.1M

Forward guidance

Assertio announced its initial 2024 operating guidance as follows: Net Product Sales (GAAP) $110.0 Million to $125.0 Million and Adjusted EBITDA (Non-GAAP) $20.0 Million to $30.0 Million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-1.9%

Avg return

Earnings day

-4.4%

Avg return

5 days after

-4.5%

Avg return

30 days after

52%

33 / 64 earnings

Positive

+33.3%

Q3 2021

Best reaction

-46.2%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+4.2%+4.7%
Q4 2025+6.5%+13.6%+53.1%
Q3 2025+13.3%-1.2%-1.2%
Q1 2025-1.8%+8.1%+0.0%
Q4 2024-7.5%-7.7%-20.5%
Q3 2024+0.2%-4.7%+12.9%
Q2 2024-12.8%-14.4%+0.8%
Q1 2024+7.8%-6.8%-2.9%
Q4 2023+10.8%+23.1%-1.1%
Q3 2023-45.5%-53.2%-50.9%
Q2 2023-46.2%-41.0%-39.0%
Q1 2023+20.6%+22.2%-3.8%
Q4 2022+7.9%-15.1%-0.6%
Q3 2022-0.4%+10.4%+38.1%
Q2 2022-4.3%-4.8%-32.6%
Q1 2022+6.2%+37.5%+52.9%
Q4 2021+13.8%-0.5%+56.9%
Q3 2021+33.3%+36.0%+18.4%
Q2 2021-2.3%-3.1%-16.3%
Q1 2021+11.8%-3.9%-11.8%
Q4 2020+4.3%-3.2%-35.1%
Q3 2020-41.8%-40.3%-37.3%
Q2 2020-13.8%-18.1%-23.4%
Q1 2020+1.3%+1.2%+21.3%
Q4 2019-35.1%-29.8%-37.7%
Q3 2019-9.6%-13.3%-14.5%
Q2 2019+1.4%-45.1%-54.2%
Q1 2019-0.4%-10.8%-37.9%
Q4 2018-5.8%-12.7%+26.8%
Q3 2018+6.5%+5.5%-16.3%
Q2 2018-19.0%-23.0%-33.5%
Q1 2018+26.5%+23.5%+10.6%
Q4 2017-11.4%-12.3%-15.0%
Q3 2017+15.4%+30.0%+68.6%
Q2 2017-35.1%-33.3%-37.4%
Q1 2017+2.3%+9.0%-3.1%
Q4 2016+4.7%-0.9%-9.9%
Q3 2016-16.1%-8.0%-12.1%
Q2 2016+5.6%+10.2%+8.7%
Q1 2016-6.2%
Q4 2015-4.1%
Q3 2015+6.7%
Q2 2015-7.2%
Q1 2015-14.1%
Q4 2014+13.4%
Q3 2014-2.7%
Q2 2014+5.5%
Q1 2014-23.5%
Q4 2013+14.8%
Q3 2013-0.5%
Q2 2013+4.0%
Q1 2013-2.8%
Q4 2012+6.2%
Q3 2012+1.5%
Q2 2012-0.5%
Q1 2012+3.2%
Q4 2011+3.3%
Q3 2011-10.4%
Q2 2011+3.1%
Q1 2011-1.2%
Q4 2010+0.6%
Q3 2010-0.2%
Q2 2010+5.2%
Q1 2010-4.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro